359 related articles for article (PubMed ID: 19450096)
21. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
Kerbaul F; Rondelet B; Demester JP; Fesler P; Huez S; Naeije R; Brimioulle S
Crit Care Med; 2006 Nov; 34(11):2814-9. PubMed ID: 16971854
[TBL] [Abstract][Full Text] [Related]
22. Pharmaco-economics of levosimendan in cardiology: a European perspective.
Nieminen MS; Buerke M; Parissis J; Ben-Gal T; Pollesello P; Kivikko M; Karavidas A; Severino P; Comín-Colet J; Wikström G; Fedele F
Int J Cardiol; 2015 Nov; 199():337-41. PubMed ID: 26241640
[TBL] [Abstract][Full Text] [Related]
23. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
[TBL] [Abstract][Full Text] [Related]
24. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
Nieminen MS; Sandell EP
Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
[TBL] [Abstract][Full Text] [Related]
25. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
26. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
[TBL] [Abstract][Full Text] [Related]
27. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
Mebazaa A; Nieminen MS; Filippatos GS; Cleland JG; Salon JE; Thakkar R; Padley RJ; Huang B; Cohen-Solal A
Eur J Heart Fail; 2009 Mar; 11(3):304-11. PubMed ID: 19158152
[TBL] [Abstract][Full Text] [Related]
28. The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.
Rossinen J; Harjola VP; Siirila-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS
Acute Card Care; 2008; 10(4):209-13. PubMed ID: 18720087
[TBL] [Abstract][Full Text] [Related]
29. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Leppikangas H; Ruokonen E; Rutanen J; Kiviniemi V; Lindgren L; Kurola J
Ann Emerg Med; 2009 Dec; 54(6):811-817.e1-3. PubMed ID: 19766354
[TBL] [Abstract][Full Text] [Related]
30. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Cavusoglu Y
Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
[TBL] [Abstract][Full Text] [Related]
31. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
32. The utility of levosimendan in the treatment of heart failure.
Lehtonen L; Põder P
Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
[TBL] [Abstract][Full Text] [Related]
33. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case.
Morais J; Dias B; Pontes N
Rev Port Cardiol; 2003; 22(7-8):941-8. PubMed ID: 14587161
[TBL] [Abstract][Full Text] [Related]
34. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
[TBL] [Abstract][Full Text] [Related]
35. Levosimendan: implications for clinicians.
McBride BF; White CM
J Clin Pharmacol; 2003 Oct; 43(10):1071-81. PubMed ID: 14517189
[TBL] [Abstract][Full Text] [Related]
36. Levosimendan: a retrospective single-center case series.
Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
[TBL] [Abstract][Full Text] [Related]
37. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of levosimendan in clinical practice.
Silva-Cardoso J; Ferreira J; Oliveira-Soares A; Martins-de-Campos J; Fonseca C; Lousada N; Ilídio-Moreira J; Rabaçal C; Damasceno A; Amorim S; Seabra-Gomes R; Ferreira R; Abreu-Lima C;
Rev Port Cardiol; 2009 Feb; 28(2):143-54. PubMed ID: 19438150
[TBL] [Abstract][Full Text] [Related]
39. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
